Home
Life Sciences
Pharmaceutical
Drug Delivery Technology
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics

Drug Delivery Technology

Summary

Table of Contents

Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics

Publication date: July 2011

Keywords : drug delivery, Drug Delivery Technology, needle-free drug delivery, Injector, vaccine delivery, injectable drug delivery, mucosal delivery

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles

» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

The line between drug delivery and drug substance will continue to become more elusive in the near future as shown in the analysis, as researchers work to improve drug properties through drug design and molecular modeling. Consequently, in the next decade, drug delivery technologies will be a focal point of competition within the pharmaceutical industry.

This Kalorama Information report, Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics takes a look at this aspect of the pharmaceutical marketplace with figures and forecasts for pharmaceutical companies and the companies that supply technology to them. The success of specific drugs will be tied to innovative delivery techniques, which will enable the targeting that will exploit the clinical properties of a new generation of drugs.

The needle-free drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to significant improvements in drug delivery. This report looks at that trend and reports current and forecasted revenues for the injectable drug delivery market, segmented into two main categories:

Needle-Free Products Market (Including Drug and Technology)

Needle-Free Products Market (Technology Only)

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. The report also includes information that will be of assistance to business planners:

Trends in the Vaccine Market

Market Size and Forecast for Needle-Free Vaccine Technology

Trends in Biopharmaceuticals

Leading Pharmaceutical Product Sold With Needle-Free Technologies

Products in Development

Detailed Profiles of Key Companies in Needle-Free Technologies.

Current Market Size and Forecasts to 2013

Needle-Free Cost Savings, Autojets, Health Care Reform, and Other Trends and Developments

Global Drug Delivery Technology Industry

CHAPTER ONE: EXECUTIVE SUMMARY: Market Drivers; Market Size and Growth; Competitor and Market Analysis; Biotech Markets
CHAPTER TWO: INTRODUCTION: Scope and Methodology; Drug Delivery Systems; Phases of Drug Action; Needle-Free Drug Delivery; Safety Concerns; Local Reactions; Needle-Free Products; Review of Major Products on the Market
CHAPTER THREE: TRENDS AND DEVELOPMENTS: Pen Injectors; Novel Vaccine Delivery Development; Delivery Systems Placement Trends; Nanotechnology; Drug Delivery Development; MicroChip Technology; DNA Vaccines; Needle-Free Delivery Development; Medical House/Dr. Reddy’s; Flugen; Inviragen; Other; Selected Products in Development
CHAPTER FOUR MARKET SIZE AND GROWTH: Competitive Landscape; Market Size and Forecast; Cost Considerations; Drivers of the Needle-free Drug Delivery Market; Biologics; Cancer; Market; Drug Delivery Development; MicroChip Technology; DNA Vaccines; Needle-Free Delivery Development; Medical House/Dr. Reddy’s; Flugen; Inviragen; Other; Selected Products in Development; Drug Delivery Technology Only Market; Needle Free Vaccine Delivery Market
CHAPTER FIVE CONCLUSIONS: Conclusion 1; Conclusion 2; Conclusion 3; Conclusion 4; Conclusion 5
CHAPTER SiX COMPANY PROFILES: ALZA Corp.; DUROS; ALZAMER; Antares Pharma, Inc.; Medi-Jector VISION; Medi-Jector MJ8; Vibex; Aridis Pharmaceuticals, Inc; Becton Dickinson and Company; Accuspray; Revenues; Bioject Medical Technologies, Inc.; Jupiter Jet; Glide Pharma; ImplaJect; Intercell AG; MedImmune, Inc; Mystic Pharmaceuticals, Inc; Optinose, Inc; Pharmajet, Inc; PowderMed, Inc/Pfizer; PowderMed; Ypsomed Holding AG; ServoPen; Zogenix Corporation; Zosano Pharma
APPENDIX: COMPANY DIRECTORY
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY: Figure 1-1: Worldwide Market for Needle-Free Delivery
CHAPTER TWO: INTRODUCTION: Table 2-1: Sequence of Drug Action
CHAPTER THREE: TRENDS AND DEVELOPMENTS: Table 3-1: Select Products in Development by Drug Delivery Companies
CHAPTER FOUR: MARKET SIZE AND GROWTH: Table 4-1: Needle-Free Drug Delivery Technology Participants; Figure 4-1: Cost per Million Injections by Injector Type; Table 4-2: Worldwide Market for Needle-Free Drug Delivery Technology and Pharmaceuticals 2009-2016; Figure 4-2: Needle-Free Drug Delivery Technology and Pharmaceuticals 2009-2016; Figure 4-3: The Worldwide Market for Needle-Free Delivery Systems, Technology Only Revenues, 2009 to 2016; Table 4-3: The Worldwide Market for Needle-Free Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2009-2016; Figure 4-4: The Worldwide Market for Needle-Free Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2011; Table 4-4: Global Immunization Rates by Vaccine Type 2008; Table 4-5: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 2002-2008; Figure 4-6: Pediatric Vaccine Market, 2005-2014; Figure 4-7: Needle Free Vaccine Delivery Systems Market, 2009-2016

Talk to Robyn

00 1 718 213 49 04

Send Your Request

Follow

Add to circles Subscribe to our RSS feeds!

Global Drug Delivery Technology Industry : Latest Reports

Injectable Drug Delivery to 2018 - Drugs, Devices, Targets, Therapeutics and Forecasts

$ 4 850
Industry report
March 2013
by Greystone Research Associates

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels ...

Drug Self-Administration Markets to 2018 - Drug Products, Indications, Markets and Forecasts

$ 4 850
Industry report
March 2013
by Greystone Research Associates

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of ...

Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017

$ 4 650
Industry report
April 2013
by MarketsandMarkets

The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery ...

Drug Delivery Technologies Market (metered ...

April 2013 $ 4 650

Implantable Drug Delivery Devices (contrac ...

March 2013 $ 4 595

Prefilled Syringes To 2018 - Devices, Drug ...

March 2013 $ 3 850

Pen Injectors - Devices, Drugs, Combinatio ...

March 2013 $ 3 850

Autoinjectors To 2018 - Devices, Therapeut ...

March 2013 $ 2 850

Infusion Pumps: Technology And Market 2013 ...

April 2013 $ 2 732

Global Smart Pill Technology Market 2012 2 ...

March 2013 $ 2 000

More Reports:

Drug Delivery Technology in China (10)

Drug Delivery Technology in India (5)

Drug Deliver... in the United States (15)

Company Reports

SkyePharma PLC

Primary Sources

GlaxoSmithKline P.L.C.

Ypsomed Holding AG

Baxa Corp.

Consort Medical PLC

Sanofi-Aventis Senegal

Nektar Therapeutics

Alkermes Inc.

Baxter International Inc.

Global Drug Delivery Technology Industry : Latest Downloads

The Future of Inhaled Delivery

Industry report
January 2013
7 pages

... Forecast the global nebulizer market to grow at a cagr of 5.1 Percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in the incidence of lung ...

Drug Delivery Technology Industry Brief

Industry report
September 2012
24 pages

... Of development and species selection for predictive pk/pd data is crucial. As previously noted, the industry norm has long perpetuated rats and dogs as the standard for nasal drug delivery studies, only ...